These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30729131)

  • 1. Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease.
    Barta Z; Czompa L; Rentka A; Zold E; Remenyik J; Biro A; Gesztelyi R; Zsuga J; Szodoray P; Kemeny-Beke A
    Biomed Res Int; 2019; 2019():8310583. PubMed ID: 30729131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
    Ozen S; Ozer MA; Akdemir MO
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
    Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
    Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R
    Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete response to artificial tears is associated with features of neuropathic ocular pain.
    Galor A; Batawi H; Felix ER; Margolis TP; Sarantopoulos KD; Martin ER; Levitt RC
    Br J Ophthalmol; 2016 Jun; 100(6):745-9. PubMed ID: 26377416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease.
    Kashkouli MB; Alemzadeh SA; Aghaei H; Pakdel F; Abdolalizadeh P; Ghazizadeh M; Moradpasandi F
    Ocul Surf; 2018 Oct; 16(4):458-462. PubMed ID: 30297028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.
    Sacchetti M; Lambiase A; Schmidl D; Schmetterer L; Ferrari M; Mantelli F; Allegretti M; Garhoefer G
    Br J Ophthalmol; 2020 Jan; 104(1):127-135. PubMed ID: 30944103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a formulated eye drop with
    Tan J; Jia T; Liao R; Stapleton F
    Br J Ophthalmol; 2020 Oct; 104(10):1373-1377. PubMed ID: 31949092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye.
    Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R
    Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of artificial tears on dynamic optical quality in patients with dry eye disease.
    Wei Z; Su Y; Su G; Baudouin C; Labbé A; Liang Q
    BMC Ophthalmol; 2022 Feb; 22(1):64. PubMed ID: 35144571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal Manifestations of Inflammatory Bowel Disease.
    Czompa L; Barta Z; Ziad H; Nemeth G; Rentka A; Aszalos Z; Zold E; Gesztelyi R; Zsuga J; Szodoray P; Kemeny-Beke A
    Semin Ophthalmol; 2019; 34(7-8):543-550. PubMed ID: 31657260
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and associated risk factors of dry eye disease in 16 northern West bank towns in Palestine: a cross-sectional study.
    Shanti Y; Shehada R; Bakkar MM; Qaddumi J
    BMC Ophthalmol; 2020 Jan; 20(1):26. PubMed ID: 31931756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of Dry Eye Patients With Chronic Pain Syndromes.
    Vehof J; Sillevis Smitt-Kamminga N; Kozareva D; Nibourg SA; Hammond CJ
    Am J Ophthalmol; 2016 Feb; 162():59-65.e2. PubMed ID: 26603488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptoms, resilience, and personality traits in dry eye disease.
    Kaiser T; Janssen B; Schrader S; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):591-599. PubMed ID: 30648207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Health Anxiety and Depressive Symptoms in Dry Eye Disease.
    Szakáts I; Sebestyén M; Németh J; Birkás E; Purebl G
    Curr Eye Res; 2016 Aug; 41(8):1044-1049. PubMed ID: 26642862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry Eye Disease: Concordance Between the Diagnostic Tests in African Eyes.
    Onwubiko SN; Eze BI; Udeh NN; Onwasigwe EN; Umeh RE
    Eye Contact Lens; 2016 Nov; 42(6):395-400. PubMed ID: 26629958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
    Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
    Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.
    Steven P; Augustin AJ; Geerling G; Kaercher T; Kretz F; Kunert K; Menzel-Severing J; Schrage N; Schrems W; Krösser S; Beckert M; Messmer EM
    J Ocul Pharmacol Ther; 2017 Nov; 33(9):678-685. PubMed ID: 28922088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.